SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

A sharp move higher has fueled intense speculation around 4CHAN as a low-cap Ethereum memecoin tied to 4chan culture, with traders emphasizing its huge token supply, purported locked liquidity and potential for FOMO. Supporters are urging holders to accumulate and expect further momentum, while skeptics characterize the move as a possible pump-and-dump and question the tokens utility and liquidity.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

Expectations of weakness in Bitcoin and MicroStrategy are driving interest in MSTZ, a leveraged inverse MSTR ETF used to hedge or trade anticipated crypto-related pullbacks. Traders are highlighting quick gains and frequent dip-and-rip scalps, while others warn that volatility and daily decay make it unsuitable for longer-term holding and can magnify losses.

Tidal Trust II - Defiance Daily Target 2X Short MU ETF

Bearish positioning around Micron and the broader memory rally is driving attention, with traders using MUZ as a leveraged hedge or short vehicle amid concerns about Chinese competition, future supply growth, and a potential post-rally selloff. The community is divided between bears calling the memory cycle exhausted and bulls pointing to strong AI-related demand and capacity booked well into the future.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is drawing attention as traders debate its muted performance relative to spot VIX and market declines, with many attributing the divergence to VIX-futures contango, roll decay, and the funds leveraged structure rather than manipulation. The community is split between shorting or buying puts because of persistent decay and expecting a volatility spike tied to Fed uncertainty, geopolitical tensions, or a broader equity correction.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

President Trumps support for bringing Hyperliquids derivatives platform into the U.S. through a compliant CFTC framework is driving attention, alongside the launch of prediction markets and fee-funded buybacks. Traders are broadly bullish on increased access and Hyperliquids revenue model, though some warn that token unlocks, dilution, and an extended rally could trigger a pullback.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

An abrupt CEO departure and broader leadership reshuffling have driven selling and uncertainty around Legend Biotechs governance and Johnson & Johnson partnership. Traders remain divided between concerns over execution, competition and China-related risks, and optimism that strong CARVYKTI growth, promising in-vivo CAR-T data and potential M&A could support a recovery.

GLOBALFOUNDRIES, Inc. provides foundry services and manufactures semiconductors. It offers global shuttle, mask, post-fab and turnkey services. The company was founded on October 7, 2008 and is headquartered in Malta, NY.

GlobalFoundries Inc

U.S. government backing for GlobalFoundries quantum-manufacturing and silicon-photonics expansion, including CHIPS-related funding and an equity stake, has made it a focal point of the AI and quantum semiconductor themes. Traders remain divided between bullish views on domestic foundry demand, photonics growth and strategic support, and bearish concerns about selling pressure, valuation and shareholder block sales.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Anticipation of ERCOTs conditional Batch Zero classifications for Ciphers Texas large-load projects, potentially covering roughly 2 GW, is the dominant catalyst, with traders focused on whether key sites clear the review and receive favorable power treatment. The community largely expects this to support an AI/HPC re-rating and future hyperscaler leases, while skeptics point to Texas regulatory risk, sector weakness, and the uncertainty that these classifications are conditional rather than final power allocations.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Bitcoins rebound is driving attention to MARA as a leveraged crypto-mining and treasury play, but traders are debating why the shares are lagging Bitcoin and other miners. The discussion also centers on heavy short interest, options-driven volatility, and whether potential AI data-center or Long Ridge lease deals can offset concerns about management, dilution, and inconsistent execution.

Daily surprises, near and far. Your source for travel inspiration and more. Travel moves you!

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Attention is centered on regulatory and legal uncertainty surrounding Paramount Skydances proposed acquisition of Warner Bros. Discovery, including stalled settlement talks with California and the looming antitrust trial. Traders are divided between expecting a settlement or eventual closing and warning that prolonged delays, fees, or a failed merger could materially pressure WBDs standalone value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Glucotrack, Inc. Announces Reverse Stock Split

Glucotrack, Inc. (Nasdaq: GCTK) (Glucotrack or the Company), a healthcare technology and biopharmaceutical company operating Lkahi Therapeutics, today announced that it will effect a 1-for-15 reverse stock split (the Reverse Stock Split) of its issued and outstanding common stock par value $0.001...

Lkahi Therapeutics Initiates Clinical Trial Manufacturing for LT-100

Lkahi Therapeutics Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced that it has started its initial Good Manufacturing Practice (GMP) manufacturing campaign for LT-100 (pure honeybee venom), the Company's lead development candidate for osteoarthritis pain.The advancement of...

Lkahi Therapeutics Expands ai Futures Lab Asset Origination Network Through Continued Collaboration with the University of Georgia

Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced the continued participation of the University of Georgias Student Industry Fellows Program in the ai Futures Lab. The renewed collaboration expands Lkahis growing nationwide network of academic institutions...

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-market session. The company's market cap stands at $1.7 million.
GlucoTrack (NASDAQ:GCTK) shares moved upwards byread more...

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation

Glucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The Panel has confirmed that Glucotrack has regained compliance with Nasdaq's stockholders' equity...

Glucotrack Announces $5.5 Million Financing

Glucotrack, Inc. (NASDAQ: GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for approximately $5.5 million in financing from participating institutional investors, including a $2.0 million equity financing priced at $0.75 per unit and a $3.5 million follow-on investment in...

Lkahi Therapeutics ai Futures Lab Changes How Biopharma Builds a Pipeline

Glucotrack (NASDAQ: GCTK) today announced the continued expansion of the ai Futures Lab operated through its wholly owned subsidiary, Lkahi Therapeutics Inc. During its first year, the ai Futures Lab identified more than 45 therapeutic opportunities on a budget of approximately $33,000 and advanced...

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session.
GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap stands atread more...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.
GlucoTrack (NASDAQ:GCTK) stock increased by 47.36% to $0.42. The market value of their outstanding shares is at $1.8read more...

Glucotrack's Lōkahi Unit Pursues Simpler Drug Delivery as LT-100 Moves Toward Its Next Clinical Milestone

Glucotrack (NASDAQ: GCTK) continues to broaden its healthcare platform beyond diabetes technology, announcing a meaningful development for its wholly owned biopharmaceutical subsidiary, Lōkahi Therapeutics, and its lead therapeutic candidate, LT-100. While Glucotrack is widely recognized for developing its long-term implantable continuous blood glucose monitoring (CBGM) system, the company is simultaneously advancing a second growth initiative through Lōkahi, which focuses on acquiring and developing overlooked therapeutic assets.

This account has been verified as an official GCTK representative.

Verified Account

Glucotrack IR

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK Stock Is Soaring Today — What Is Fueling The Surge?

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

GCTK GlucoTrack Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest GCTK News